Evolus, Inc.
EOLS
Clasificación en acciones
#13236
Evolus, Inc. is a performance beauty enterprise that furnishes the United... Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
Precio por acción
$7.37
Última sincronización: 2026-10-20
Capitalización bursátil
$486.98M
Cambio (1 día)
0.17%
Cambio (1 año)
-49.43%
País
US
Comercio Evolus, Inc. (EOLS)
Categoría
Healthcare
Ganancias de Evolus, Inc. (EOLS)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Evolus, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Evolus, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| Not enough data for the provided dates. | ||
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
